# 2026-23542: FDA Renews Survey Tracking Tobacco Use Among America's Young People

2026-23542, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; National Youth Tobacco Survey, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-11-19, effective Submit written comments (including recommendations) on the collection of information by December 21, 2026.; PRIA reads it as touching household money (as of 2026-11-19).

- Canonical: https://policyrisk.com/federal-register/2026-23542
- As of: 2026-11-19
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-23542
- Title: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; National Youth Tobacco Survey
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 74587
- Published: 2026-11-19
- Effective: Submit written comments (including recommendations) on the collection of information by December 21, 2026.
- Comments close: 2026-12-21
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-11-19

## In one line

FDA Renews Survey Tracking Tobacco Use Among America's Young People

## Summary

The FDA is updating its National Youth Tobacco Survey for 2027-2029 to keep track of tobacco use among young people across the U.S. This helps the FDA fight youth tobacco use and protect kids from harmful products. They’re asking for public comments by December 21, 2026, so everyone can weigh in before the survey moves forward.

## Abstract

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

## Effects PRIA read

- More Students and Schools Will Be Sampled: mixed, medium. FDA will increase the total number of schools and students sampled for the National Youth Tobacco Survey for 2027-2029 to respond to falling school-based response rates (which fell from 77.2% in 2019 to 36.0% in 2025). This change is intended to keep the survey nationally representative but also in…
- Student Time to Complete Survey (45 Minutes): cost, low. If you are a student in grades 6–12 selected for NYTS, the survey is digital, anonymous, self-administered, and takes about 0.75 hours (45 minutes) to complete. FDA estimates 29,579 student responses for 2027-2029, totaling 22,184 respondent hours.
- Parents May Spend Time on Active Consent Forms: cost, low. FDA estimates that 3,500 parents/guardians may need to complete active consent forms requiring about 0.17 hours (10 minutes) each, totaling 595 hours. FDA notes about 10% of respondents are estimated to require active parental consent where schools require it.
- School Staff Will Spend Time on Recruitment and Administration: cost, low. State administrators (42), district administrators (384), school administrators (555), and teachers (1,388) have estimated time burdens for recruitment or administration: 0.5 hours (30 minutes) for administrators, 0.25 hours (15 minutes) for teachers, and other small activities. Total non-student r…
- Public-Use Data Will Be Released Alongside First Publication: benefit, low. To comply with Executive Order 14303, FDA plans to release the NYTS public-use dataset at the same time as the first publication of NYTS findings for a given year. This is intended to make the data available to researchers, clinicians, and policy makers more quickly and transparently.

## Related documents

- [2026-23351](https://policyrisk.com/federal-register/2026-23351): Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition, 2026-11-17
- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25

## Sources
- [2026-23542 on federalregister.gov](https://www.federalregister.gov/documents/2026/11/19/2026-23542/agency-information-collection-activities-submission-for-office-of-management-and-budget-review)
- [2026-23542 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-11-19/pdf/2026-23542.pdf)

## Related
- [Previous: 2026-23541, Agency Information Collection Activities; Submission for Office of Management a…](https://policyrisk.com/federal-register/2026-23541)
- [Next: 2026-23544, Competitive Postal Products](https://policyrisk.com/federal-register/2026-23544)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-23542 (as of 2026-11-19).
